Melon Global care is a leading pharmaceutical company in India, with a diverse range of finished pharmaceutical products. Get to Know Us We, Melon Global Care, continuously cater to the requirements of the pharmaceutical industry by utilizing comprehensive knowledge of the industry, a consumer mindset, and continuous R & D activities. Since our incorporation in 2018, we have established a strong presence in global markets. We are a well-known producer, exporter, and third-party manufacturer of anti-cancer injections, HIV care medicines, hepatitis medicine, kidney care medicine, etc. other pharmaceutical products.
In India, favipiravir is the first oral medication approved for the treatment of COVID-19. Favipiravir 200mg Tablets is an antiviral medication with a wide range of action. It was finally approved as a treatment for mild to moderate coronavirus infection (COVID-19)
Favipiravir is an antiviral drug developed in Japan that has been approved for the treatment of influenza. It was said to have antiviral activity against all influenza virus subtypes. It not only prevents influenza A and B replication, but it has also shown promise in the treatment of avian influenza and as a possible diagnosis for influenza strains resistant to the first-line treatment.
COVID-19 patients with co-morbid conditions including diabetes and heart disease who have mild to moderate COVID-19 symptoms may take favipiravir.
Contraindications
Pregnant women and women who might be pregnant do not take favipiravir.
